Home / Research Tools
Research Tools
| | Corporate Profile: Arc Exploration Limited
Publisher: Kaiser Research Online
Author: Copyright 2017 John A. Kaiser
|
| |
| Arc Exploration Ltd (ARX-ASX) |
|---|
| Trade Date | Volume | High | Low | Close | Chg | Status |
| April 18, 2024 | 0 | $0.17 | $0.17 | $0.17 | $0.00 | Trading |
Issued
45,059,482 |
Price
$0.165 |
Working Capital
$3,164,142 |
Key People: Jeffery Malaihollo (CEO), Simon O'Loughlin (Chair), Cahyono Halim (CFO), |
Diluted
45,559,482 |
Insiders
0.8% |
As of
6/30/2019 |
| Company supplied Corporate Overview - not available |
| The free corporate profile serves as a fast gateway for KRO members via the map cards to resources such as the KRO Profile which includes financial, insider and project details as well as news releases and KRO comments for which headline links are provided below. Links to the company's web site and project web pages are available within this free corporate profile if the company has a multi-user corporate membership (they are always available in full member only KRO Profile). A corporate membership provides the company with complete multiple user access to KRO resources and entitles the company to provide a corporate overview for the subject company's unrestricted corporate profile. |
| Active Project List |
| Project | Country | State/Prov | Region | Net
Interest | Stage | IPV $
MM | Target Metals | Deposit Style | TSC |
| (Project Name has a link to its location in the Members only KRO Profile) |
 |
Trenggalek |  | Indonesia | Other | Not Applicable | 95% WI | 1-Grassroots |
$8 | Gold Silver | Epithermal |
 |
| Company Project Gateway |
| Trenggalek Project |
|
Company Project Web Page - N/A |
|
Indonesia - Other |
95% WI | 1-Grassroots |
Gold Silver | Epithermal |
|
|
| Apr 8, 2024 | Notification of cessation of securities - ARX |
| Apr 4, 2024 | Final Director's Interest Notice - SE |
| Mar 28, 2024 | Change of Director's Interest Notice - SE |
| Mar 28, 2024 | Application for quotation of securities - ARX |
| Mar 28, 2024 | Section 708A Notice |
| Mar 22, 2024 | Initial Director's Interest Notice - DH |
| Mar 22, 2024 | Intuitive's Darla Hutton joins Board, Steven Engle retires |
| Feb 23, 2024 | Change of Director's Interest Notice - PM |
| Feb 20, 2024 | Change in substantial holding |
| Feb 14, 2024 | Notification of cessation of securities - ARX |
| Feb 14, 2024 | Application for quotation of securities - ARX |
| Feb 14, 2024 | Section 708A Notice |
| Jan 30, 2024 | Investor Presentation |
| Jan 30, 2024 | December 2023 Quarterly Report and Appendix 4C |
| Jan 25, 2024 | Enivo Clinical Pilot Study |
| Jan 23, 2024 | Notification of Quarterly Results Webinar |
| Jan 12, 2024 | Notification of cessation of securities - ARX |
| Nov 28, 2023 | Aroa Half Year Results Presentation |
| Nov 28, 2023 | Aroa Biosurgery Half Yearly Results H1 FY24 |
| Nov 28, 2023 | Appendix 4D and Half Year Report |
| Nov 22, 2023 | Notification of Half Year Results Webinar |
| Nov 21, 2023 | AROA Investor Event |
| Nov 14, 2023 | Bell Potter Healthcare Conference Presentation |
| Oct 31, 2023 | Investor Presentation |
| Oct 31, 2023 | September 2023 Quarterly Report and Appendix 4C |
| Oct 27, 2023 | Notification regarding unquoted securities - ARX |
| Oct 24, 2023 | Notification of Quarterly Results Webinar |
| Oct 3, 2023 | Study shows positive outcomes for Myriad in traumatic wounds |
| Sep 7, 2023 | Section 708A Notice |
| Sep 7, 2023 | Change of Director's Interest Notice - JM |
| Sep 7, 2023 | Application for quotation of securities - ARX |
|
| |
| | You can return to the Top of this page
|
|
